PLAGL2 is involved in a variety of cancers including colon cancer, acute myeloid leukemia, malignant glioma, and lung adenocarcinoma, and PLAGL2 can function as a tumor suppressor by initiating cell cycle arrest and apoptosis [26]. This evidence concerns the gene PLAGL2 and malignant glioma.